BICARA THERAPEUTICS INC (BCAX) Stock Cash Flow
NASDAQ:BCAX - Nasdaq - US0554771032 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -52.86M | -68.00M | -51.98M | -37.84M | |||
| Depreciation Amortization | 56.00K | 56.00K | 19.00K | 10.00K | |||
| Change In Working Capital | 624.00K | -14.13M | -9.62M | 4.95M | |||
| Other non cash items | -5.05M | 7.32M | 15.96M | 810.00K | |||
| OPERATING CASH FLOW | -57.23M | -74.75M | -45.63M | -32.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | 515.00K | -71.00K | -586.00K | -192.00K | |||
| Other Investing Activity | N/A | 62.00K | N/A | N/A | |||
| INVESTING CASH FLOW | 577.00K | -9.00K | -586.00K | -192.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Stock Issued/Repurchased | 61.99M | 334.03M | 272.50M | 31.70M | |||
| FINANCING CASH FLOW | 61.99M | 334.03M | 272.50M | 31.70M | |||
| CHANGE IN CASH | 5.34M | 259.27M | 226.28M | -573.00K | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -57.23M | -74.75M | -45.63M | -32.08M | |||
| Capital Expenditure | 515.00K | -71.00K | -586.00K | -192.00K | |||
| FREE CASH FLOW | -56.71M | -74.82M | -46.21M | -32.27M | |||
All data in USD